A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Julian BiauEmilie ThivatCorinne MillardetNicolas SaroulNathalie Pham-DangIoana MolnarBruno PereiraXavier DurandoJean BourhisMichel LapeyrePublished in: BMC cancer (2020)
Clinicaltrials.gov : NCT03401840 , registered on 17-1-2018. Identifier in French National Agency for the Safety of Medicines and Health Products (ANSM): N°ID - RCB 2017-A02058-45, registered on July 2017. Protocol version: Version 3 dated from 25th November 2019.
Keyphrases
- early stage
- phase ii study
- radiation therapy
- locally advanced
- psychometric properties
- open label
- public health
- healthcare
- randomized controlled trial
- neoadjuvant chemotherapy
- sentinel lymph node
- rectal cancer
- mental health
- phase ii
- study protocol
- patients undergoing
- radiation induced
- phase iii
- quality improvement
- squamous cell carcinoma
- health information
- cross sectional
- placebo controlled
- lymph node
- climate change
- small cell lung cancer
- double blind
- young adults
- brain metastases